ORE1001

· Ore Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORE1001, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis [Phase 1, Phase 2]